Advertisement
UK markets open in 4 hours 2 minutes

  • NIKKEI 225

    38,527.60
    -309.86 (-0.80%)
     

  • HANG SENG

    18,654.22
    +210.11 (+1.14%)
     

  • CRUDE OIL

    73.21
    -0.04 (-0.05%)
     

  • GOLD FUTURES

    2,351.00
    +3.60 (+0.15%)
     

  • DOW

    38,711.29
    +140.26 (+0.36%)
     

  • Bitcoin GBP

    55,473.59
    +1,400.07 (+2.59%)
     

  • CMC Crypto 200

    1,480.41
    +33.26 (+2.30%)
     

  • NASDAQ Composite

    16,857.05
    +28.38 (+0.17%)
     

  • UK FTSE All Share

    4,496.88
    -20.15 (-0.45%)
     
Pensions:

The future of life time allowance

How Labour and Conservative policies will impact pension planning

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

Toi Management, LLC
·1-min read
Toi Management, LLC
Toi Management, LLC

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com